Minimally Invasive Therapeutic Drug Monitoring of Immunosuppressants in Children with Kidney Diseases: Validation of

Marika Ishii1, Jun Aoyagi1, Natsuka Kimura2

  • 1Department of Pediatrics, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.

Insights

Minimally invasive fingerstick blood tests accurately measure immunosuppressant drug levels in children, offering a less burdensome alternative to traditional venous draws for therapeutic drug monitoring.

Area of Science:

  • Pharmacology
  • Pediatric Nephrology
  • Analytical Chemistry

Background:

  • Therapeutic drug monitoring (TDM) of immunosuppressants is crucial for pediatric kidney disease management.
  • Repeated venipuncture for TDM poses a significant burden on pediatric patients.
  • Evaluating less invasive sampling methods is essential to improve patient compliance and reduce procedural stress.

Purpose of the Study:

  • To assess the analytical comparability of immunosuppressant drug concentrations measured from minimally invasive fingerstick capillary blood samples versus conventional venous blood samples.
  • To determine the reliability of using microvolume capillary sampling for therapeutic drug monitoring in pediatric patients.

Main Methods:

  • Collected 2.8 µL of capillary whole blood via fingersticks from pediatric patients on immunosuppressants.
  • Quantified drug concentrations (mycophenolate mofetil, tacrolimus, cyclosporine A) using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method.
  • Compared capillary results with conventional venous samples using linear regression and Bland-Altman analyses.

Main Results:

  • Strong correlations (R² > 0.90) were observed between capillary and venous samples for mycophenolic acid, tacrolimus, and cyclosporine A.
  • Hematocrit correction enhanced agreement for mycophenolic acid measurements.
  • Bland-Altman analyses indicated acceptable bias, supporting the analytical reliability of capillary sampling.

Conclusions:

  • Fingerstick-based microvolume sampling coupled with LC-MS/MS offers a reliable method for immunosuppressant quantification in pediatric patients.
  • This minimally invasive approach has the potential to reduce procedural burden and facilitate outpatient or home-based TDM strategies.
  • Further clinical validation is warranted to fully integrate this method into routine pediatric care.